Showing results (1201-1210 of 1,883) with videos related to

Sort By:
Pageof 189
The Journal of Urology|September 11, 2013
Phase II study on the efficacy and safety of the EP1 receptor antagonist ONO-8539 for nonneurogenic overactive bladder syndromeC R Chapple, P Abrams, K-E Andersson, et al.
European Urology|August 13, 2013
Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trialPhilip van Kerrebroeck, Christopher Chapple, Ted Drogendijk, et al.
European Urology|December 1, 2012
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladderChristopher R Chapple, Steven A Kaplan, David Mitcheson, et al.
Frontiers in Immunology|April 16, 2019
Oral Neutrophils Characterized: Chemotactic, Phagocytic, and Neutrophil Extracellular Trap (NET) Formation PropertiesCarolyn G J Moonen, Josefine Hirschfeld, Lili Cheng, et al.
European Journal of Epidemiology|January 20, 2018
Cancer incidence among children and young adults who have undergone x-ray guided cardiac catheterization proceduresRichard W Harbron, Claire-Louise Chapple, John J O'Sullivan, et al.
BMC Pregnancy and Childbirth|April 5, 2023
Co-occurrence of depression, anxiety, and perinatal posttraumatic stress in postpartum personsShelby Howard, Caitlin Witt, Karla Martin, et al.
The Journal of Infectious Diseases|January 20, 2024
Cannabis Use Associates With Reduced Proviral Burden and Inflammatory Cytokine in Tissues From Men With Clade C HIV-1 on Suppressive Antiretroviral TherapyZhou Liu, Peter Julius, Cordilia Maria Himwaze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2020
Developing and Implementing an Imaging Optimization Study in Pediatric Nuclear Medicine: Experience and Recommendations from an IAEA-Coordinated Research ProjectGian Luca Poli, Marco Coca, Leonel Torres, et al.
European Urology|August 6, 2014
Efficacy of the β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post hoc analysis of pooled data from three randomised phase 3 trialsChristopher Chapple, Vik Khullar, Victor W Nitti, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 18, 2015
The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trialsD Castro-Diaz, C R Chapple, Z Hakimi, et al.
Pageof 189